| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.04▲ | 10.04▲ | 10.02▲ | 10.10▼ | 10.26▼ |
| MA10 | 10.06▼ | 10.01▲ | 10.03▲ | 10.30▼ | 10.10▼ |
| MA20 | 10.04▲ | 10.02▲ | 10.01▲ | 10.33▼ | 8.33▲ |
| MA50 | 10.01▲ | 10.05▼ | 10.30▼ | 10.13▼ | 6.47▲ |
| MA100 | 10.01▲ | 10.29▼ | 10.38▼ | 8.24▲ | 8.64▲ |
| MA200 | 10.00▲ | 10.37▼ | 10.03▲ | 6.65▲ | 9.13▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.009▲ | 0.020▲ | -0.094▼ | 0.146▲ |
| RSI | 52.201▲ | 51.042▲ | 47.747▼ | 49.009▼ | 62.296▲ |
| STOCH | 38.056 | 56.302 | 38.542 | 13.606▼ | 63.312 |
| WILL %R | -45.000 | -51.563 | -51.563 | -89.098▼ | -35.163 |
| CCI | -127.957▼ | 26.840 | 53.068 | -77.380 | 40.872 |
|
Thursday, December 11, 2025 04:17 AM
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable tolerability across all dose levelsEncouraging early clinical anti-tumor ...
|
|
Monday, November 17, 2025 05:15 AM
Immatics (IMTX) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.5. This compares to a loss of $0.12 per share a year ago. These figures are ...
|
|
Sunday, November 16, 2025 04:00 PM
Fintel reports that on November 19, 2025, Mizuho maintained coverage of Immatics N.V. (NasdaqCM:IMTX) with a Outperform recommendation. As of November 17, 2025, the average one-year price target for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 10.12 | 10.2197 | 9.88 | 10.04 | 238,483 |
| 11/12/25 | 9.89 | 10.13 | 9.8601 | 10.04 | 639,315 |
| 10/12/25 | 10.12 | 10.30 | 9.89 | 10.06 | 536,284 |
| 09/12/25 | 10.23 | 10.4156 | 9.98 | 10.08 | 274,339 |
| 08/12/25 | 10.18 | 10.50 | 9.75 | 10.28 | 637,001 |
| 05/12/25 | 10.96 | 10.96 | 9.91 | 10.18 | 1,649,444 |
| 04/12/25 | 10.33 | 12.41 | 9.98 | 11.87 | 1,016,401 |
| 03/12/25 | 9.89 | 10.52 | 9.76 | 10.34 | 258,813 |
| 02/12/25 | 10.24 | 10.50 | 9.88 | 9.89 | 408,037 |
| 01/12/25 | 10.49 | 10.59 | 10.17 | 10.26 | 438,071 |
|
|
||||
|
|
||||
|
|